| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:06 | Foresight Environmental FY26 slides: 6.2% NAV return, dividend raised | ||
| 14:06 | Castor Maritime to acquire bulk carrier for $37.5 million | ||
| 14:06 | Mortimer BTL 2021-1 redeems notes, delists from LSE | ||
| 14:06 | Tutor Perini offers $400M senior notes due 2033 | ||
| 14:06 | Aroundtown buys back 897,161 shares in latest tranche | ||
| 14:06 | H.C. Wainwright reiterates Elicio Therapeutics stock rating at buy | ||
| 14:06 | H.C. Wainwright reiterates Cognition Therapeutics stock rating on patent news | ||
| 14:06 | LB Pharmaceuticals stock rating maintained at buy by H.C. Wainwright | ||
| 14:06 | H.C. Wainwright raises Ocular Therapeutix price target to $25 on FDA pathway clarity | ||
| 14:06 | H.C. Wainwright reiterates Zymeworks stock rating on ADC data | ||
| 14:06 | H.C. Wainwright reiterates Innoviva stock rating on drug delivery platform | ||
| 14:06 | H.C. Wainwright reiterates MapLight Therapeutics stock rating on muscarinic mechanism potential | ||
| 14:06 | BioMarin stock maintained at Neutral by H.C. Wainwright on trial data | ||
| 13:42 | Organon completes licensing deal for hormone-free IUD Miudella | ||
| 13:42 | Rayonier Advanced Materials appoints Daniel Krawczyk as CEO | ||
| 13:42 | AMC reports busiest 2026 weekend with 4.8M attendees | ||
| 13:42 | Quantum Cyber meets with lawmakers, advances facility purchase | ||
| 13:42 | BridgeBio to present achondroplasia study data at congress | ||
| 13:42 | FDA grants rolling review for Palvella's microcystic LM therapy | ||
| 13:42 | Sky Quarry refinery in Nevada to begin operations in July | ||
| 13:42 | Regenxbio aligns with FDA on gene therapy resubmission path | ||
| 13:42 | Nuvectis licenses two clinical-stage drugs from Haisco | ||
| 13:42 | BrainsWay expands U.S. insurance coverage for depression treatment | ||
| 13:42 | Guggenheim cuts Kroger stock price target to $71 on pricing strategy | ||
| 13:42 | Guggenheim cuts Accenture stock price target on weak outlook |